Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A
Clinical trial NCT04418414 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04418414
- Sponsor
- Expression Therapeutics, LLC
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2029-08-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.